10x Genomics, Inc.
10x Genomics, Inc. (TXG) Stock Overview
Explore 10x Genomics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.8B
P/E Ratio
-10.88
EPS (TTM)
$-1.30
ROE
-0.22%
TXG Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of 10x Genomics, Inc. (TXG) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 61.95, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $17.82.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -10.88 and a market capitalization of 1.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.